Micro Labs Limited Cefuroxime Export Data — India (DGFT 2022–2026)

Name: Micro Labs Limited Cefuroxime Export Records India — #7 Exporter, 164 Shipments, $3.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cefuroxime

India Pharmaceutical Trade Intelligence

$129.6M440 Suppliers150 CountriesHS 30042019

ExportsIndia → UNITED STATES17.0%India → BRAZIL14.7%

ImportsITALY → India$797.7M UNITED KINGDOM → India$600.4K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: M/S. RANBAXY

Micro Labs Limited — Cefuroxime Exporter #7 | $3.0M Trade Value | TransData Nexus | TransData Nexus

Micro Labs Limited — Cefuroxime Exporter Profile

Indian Pharmaceutical Exporter · #7 for Cefuroxime · $3.0M export value · DGFT Verified

Micro Labs Limited is the #7 Indian exporter of Cefuroxime with $3.0M in export value and 164 verified shipments. Micro Labs Limited holds a 2.3% market share in Cefuroxime exports across 12 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.

Micro Labs Limited — Cefuroxime Export Profile: Buyers & Destinations

Micro Labs Limited Cefuroxime export treemap — buyers and destination countries | TransData Nexus

Where Does Micro Labs Limited Export Cefuroxime?

Country	Value	Shipments	Share
KENYA	$1.0M	46	37.8%
NIGERIA	$650.5K	17	24.0%
SRI LANKA	$331.9K	12	12.2%
MAURITIUS	$186.0K	28	6.9%

Who Are the Top Buyers of Cefuroxime from Micro Labs Limited?

Buyer	Country	Value	Orders
M/S LABOREX KENYA LIMITED	KENYA	$498.2K	22
GENEITH PHARMACEUTICALS LIMITED	NIGERIA	$434.3K	11
MICRO HEALTHCARE (PRIVATE) LIMITED	SRI LANKA	$308.8K	11
M S LABOREX KENYA LIMITED	KENYA	$275.7K	10
MICRO NOVA PHARMACEUTICALS IND	NIGERIA	$216.3K	6
LABOREX KENYA LIMITED	KENYA	$142.7K	8
LABOREX UGANDA LIMITED	UGANDA	$134.8K	13
FTM (MAURITIUS) LIMITED	MAURITIUS	$127.5K	19
BROWN AND BURK PHILIPPINES INC	PHILIPPINES	$56.2K	2
ADK PHARMACEUTICAL COMPANY PVT.	MALDIVES	$48.8K	4

Micro Labs Limited supplies Cefuroxime to 41 buyers globally. The largest buyer is M/S LABOREX KENYA LIMITED (KENYA), followed by GENEITH PHARMACEUTICALS LIMITED (NIGERIA) and MICRO HEALTHCARE (PRIVATE) LIMITED (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cefuroxime Formulations Does Micro Labs Limited Export?

Product Description / Formulation	Value	Shipments
PULMOCEF 500 ( (Cefuroxime Axetil Tablet	$193.9K	9
CEFUROXIME AXETIL TABLETS USP 500MG - 10	$100.0K	2
MICROCEF 500 (CEFUROXIME AXETIL 500MG US	$98.3K	3
PULMOCEF 250 ( (Cefuroxime Axetil Tablet	$86.6K	5
PULMOCEF 500 ( (Cefuroxime Axetil 500mg	$65.0K	4
PULMOCEF-500 ( (Cefuroxime Axetil Tablet	$60.1K	2
PULMOCEF-500 (CEFUROXIME AXETIL 500MG US	$50.0K	1
PULMOCEF 500 CEFUROXIME AXETIL TABLETSUSP 500MG 10X1X10X65240	$50.0K	1
MICROCEF 500 CEFUROXIME AXETIL 500MG USP TABLETS 1X10 S 63442	$50.0K	1
PULMOCEF 500 CEFUROXIME AXETIL TABLETSUSP 500MG - 10X1X10'SX4752	$50.0K	1

Micro Labs Limited exports 135 distinct Cefuroxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PULMOCEF 500 ( (Cefuroxime Axetil Tablet with 9 shipments worth $193.9K.

How Does Micro Labs Limited Compare to Nearest Cefuroxime Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	THEON PHARMACEUTICALS LIMITED	$7.5M	586	8	$12.7K
6	NECTAR LIFE SCIENCES LIMITED	$4.0M	120	17	$33.4K
7	MICRO LABS LIMITED ★	$3.0M	164	12	$18.0K
8	INNOVA CAPTAB LIMITED	$2.8M	172	10	$16.4K
10	CIPLA LIMITED	$2.3M	118	4	$19.1K

Micro Labs Limited ranks #7 among 440 Indian Cefuroxime exporters. Average shipment value of $18.0K compared to the market average of $188.4K. The closest competitors by value are THEON PHARMACEUTICALS LIMITED and NECTAR LIFE SCIENCES LIMITED.

Which Indian Ports Ship Cefuroxime Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	707	10.2%
SAHAR AIR	670	9.6%
NHAVA SHEVA SEA (INNSA1)	661	9.5%
HYDERABAD ICD	316	4.5%
DELHI AIR	312	4.5%
DELHI AIR CARGO ACC (INDEL4)	300	4.3%
JNPT/ NHAVA SHEVA SEA	281	4.0%
HYDERABAD ICD (INSNF6)	278	4.0%

Geopolitical & Trade Policy Impact on Micro Labs Limited's Cefuroxime Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)

Micro Labs Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)

However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cefuroxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 174 individual customs records matching Micro Labs Limited exporting Cefuroxime, covering 135 formulations to 13 countries via 41 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 150+ countries, 1,458+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cefuroxime

Cefuroxime

Micro Labs Limited — Cefuroxime Exporter Profile

Micro Labs Limited — Cefuroxime Export Profile: Buyers & Destinations

Where Does Micro Labs Limited Export Cefuroxime?

Who Are the Top Buyers of Cefuroxime from Micro Labs Limited?

What Is India's Total Cefuroxime Export Value and How Much Does Micro Labs Limited Contribute?

What Is the Average Shipment Value for Micro Labs Limited's Cefuroxime Exports?

How Does Micro Labs Limited Compare to Other Indian Cefuroxime Exporters?

What Cefuroxime Formulations Does Micro Labs Limited Export?

Regulatory Requirements: Exporting Cefuroxime to Key Markets

Nigeria — NAFDAC

How Does Micro Labs Limited Compare to Nearest Cefuroxime Exporters?

Which Indian Ports Ship Cefuroxime Exports?

Geopolitical & Trade Policy Impact on Micro Labs Limited's Cefuroxime Exports

Micro Labs Limited — Regulatory Compliance & Quality Standards

About Micro Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cefuroxime Export Data from Micro Labs Limited

Cefuroxime Stats

Company Overview

Top Products by Micro Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source